2034: Dry AMD market size forecast to reach $6.7B at 19.8% CAGR due to rising prevalence, diagnostics, and therapy launches.
2023 Dry AMD market size is over USD 1.3 billion across 7 major markets, and is forecasted to reach over USD 6.7 billion by 2034 at a CAGR of 19.8%. This growth is driven by rising disease prevalence, improved diagnostics, increased healthcare spending, and emerging therapy launches. Companies like Alkeus, Belite Bio, Aviceda, Johnson & Johnson, Allegro Ophthalmics, and others are developing innovative treatments for this growing market.
April 22, 2024
3 Articles